Metheptazine

Metheptazine is an opioid analgesic from the phenazepane family. It was developed by American Home Products in the 1950s.[1]

Metheptazine
Clinical data
Other namesMetheptazine
ATC code
  • none
Identifiers
IUPAC name
  • methyl 1,2-dimethyl-4-phenylazepane-4-carboxylate
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
Chemical and physical data
FormulaC16H23NO2
Molar mass261.365 g·mol−1
3D model (JSmol)
SMILES
  • O=C(OC)C2(c1ccccc1)CC(N(C)CCC2)C
InChI
  • InChI=1S/C16H23NO2/c1-13-12-16(15(18)19-3,10-7-11-17(13)2)14-8-5-4-6-9-14/h4-6,8-9,13H,7,10-12H2,1-3H3 Y
  • Key:RAAFYFKWMRWOIT-UHFFFAOYSA-N Y
 NY (what is this?)  (verify)

Metheptazine produces similar effects to other opioids, including analgesia, sedation, dizziness and nausea.

Metheptazine is not listed as a controlled substance under the Controlled Substances Act 1970 in the United States.[2] The Canadian Controlled Drugs and Substances Act specifically excludes the phenazepine opioids from control.

References
  1. US 3316244, Bell SC, Childress SJ, "Process for the preparation of hexahydro-1,3-dimethyl-4-phenylazepine-4-carboxylic acid, ethyl ester", issued 25 April 1967, assigned to American Home Products Corporation.
  2. "Conversion Factors for Controlled Substances". U.S. Department of Justice, Drug Enforcement Administration, Diversion Control Division.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.